Point Biopharma Global Inc (PNT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Sales | 2,790 | 4,866 | 9,457 | 0 | 0 |
| Gross Profit | 2,790 | 4,866 | 9,457 | N/A | N/A |
| Operating Expenses | 32,416 | 36,365 | 31,921 | 35,217 | 24,637 |
| Operating Income | -29,626 | -31,499 | -22,463 | 191,362 | -24,637 |
| Other Income | 5,723 | 5,167 | 5,694 | 2,746 | 804 |
| Pre-tax Income | -23,903 | -26,332 | -16,769 | 194,108 | -23,833 |
| Income Tax | 871 | -921 | -239 | 30,841 | 181 |
| Net Income Continuous | -24,774 | -25,411 | -16,531 | 163,267 | -24,013 |
| Net Income | $-24,774 | $-25,411 | $-16,531 | $163,267 | $-24,013 |
| EPS Basic Total Ops | -0.23 | -0.24 | -0.16 | 1.75 | -0.26 |
| EPS Basic Continuous Ops | -0.23 | -0.24 | -0.16 | 1.75 | -0.26 |
| EPS Diluted Total Ops | -0.23 | -0.24 | -0.16 | 1.73 | -0.26 |
| EPS Diluted Continuous Ops | -0.23 | -0.24 | -0.16 | 1.74 | -0.26 |
| EPS Diluted Before Non-Recurring Items | -0.23 | -0.24 | -0.16 | 1.53 | -0.26 |
| EBITDA(a) | $-31,153 | $-34,621 | $-25,086 | $-36,322 | $-24,547 |